VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Bioventus Inc. (BVS) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Medical Devices · market value about $748M · P/E 13.7 · revenue $586M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows